SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-21-063812
Filing Date
2021-05-10
Accepted
2021-05-10 16:01:09
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2039434d6_s1.htm S-1 2561375
2 EXHIBIT 3.2 tm2039434d6_ex3-2.htm EX-3.2 195917
3 EXHIBIT 10.12 tm2039434d6_ex10-12.htm EX-10.12 25053
4 EXHIBIT 10.13 tm2039434d6_ex10-13.htm EX-10.13 34652
5 EXHIBIT 10.14 tm2039434d6_ex10-14.htm EX-10.14 50403
6 EXHIBIT 23.1 tm2039434d6_ex23-1.htm EX-23.1 2725
7 EXHIBIT 23.3 tm2039434d6_ex23-3.htm EX-23.3 3025
8 EXHIBIT 23.4 tm2039434d6_ex23-4.htm EX-23.4 3109
9 GRAPHIC tm2039434d6_s1img001.jpg GRAPHIC 28037
10 GRAPHIC tm2039434d6_s1img002.jpg GRAPHIC 80176
11 GRAPHIC tm2039434d6_s1img003.jpg GRAPHIC 34810
12 GRAPHIC tm2039434d6_s1img004.jpg GRAPHIC 81043
13 GRAPHIC tm2039434d6_s1img005.jpg GRAPHIC 35706
  Complete submission text file 0001104659-21-063812.txt   3235748
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-1 | Act: 33 | File No.: 333-255955 | Film No.: 21906953
SIC: 2834 Pharmaceutical Preparations